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Primary structure of elongation factor 17 from Artemia 
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Complementary DNA corresponding toelongation factor 17, which forms a complex with EF-Ifl, has been 
cloned. A 2gtll cDNA library has been screened with an antiserum against EF-lflT. The derived amino 
acid sequence of EF-17 corresponds to429 amino acids excluding the initiator methionine, which is absent 
in the mature protein. About half of the protein was sequenced by direct protein sequence analysis. No 
clear homology with any other protein was found. 
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1. INTRODUCTION 
Elongation factor 1 participates in protein syn- 
thesis by mediating the transport of aminoacyl- 
tRNA to 80 S ribosomes [1]. The protein consists 
of three subunits EF-ltr, EF-lf l  and EF-I-r which 
in Artemia possess molecular masses of 49, 26 and 
46 kDa, respectively [2]. The EF- lce.GTP form 
binds aminoacyl-tRNA and transports it to the 
ribosome. After releasing the aminoacyl-tRNA 
and hydrolysis of GTP, EF- Ioe.GDP leaves the 
ribosome. EF-Ic~.GDP is then converted into 
EF-lte. GTP with the aid of EF-Ifl 7 and exogenous 
GTP.  The actual nucleotide exchange activity 
resides in EF- I~ [3-6]; EF-17 is an EF-I~' 
associated protein, which is typical for eucaryotes 
and exerts a stimulatory effect on EF-I~; its actual 
function seems related to facilitate EF- I~ activity 
at different locations in the cell [7]. 
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The nucleotide sequence presented here has been submit- 
ted to the EMBL/GenBank database under the accession 
number Y00700 
Recently, we determined the primary structure 
of EF-lf l  of Artemia from its cDNA sequence as 
well as from partial protein sequence analysis [8]. 
Here we report the primary structure of EF-17, us- 
ing the same approach. 
2. MATERIALS AND METHODS 
2.1. Materials 
Artemia cysts were purchased from Metaframe 
(San Francisco), Freund's adjuvant was purchased 
from Calbiochem and peroxidase-conjugated goat 
anti-rabbit antibodies were obtained from Miles. 
Enzymes were from Boehringer, Miles, PL- 
Pharmacia or Promega and [32P]nucleotides and 
nick-translation kits were obtained from Amer- 
sham. The other chemicals were of the highest 
grade commercially available. 
2.2. Preparations 
EF-17 was isolated as described before [8]. Dur- 
ing the dialysis of the ~7-complex against 5 mM 
pyrophosphate, pH 6.0, 2.5 mM MgCl2, EF-17 
was occasionally split by an endogenous protease. 
A distinct fragment of EF-17 with a molecular 
mass of 24 kDa was isolated on a DEAE-cellulose 
column. This fragment was also used for direct se- 
quence analysis. 
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2.3. Preparation and separation of peptides 
S-Pyridylethylation r S-carboxymethylation of 
EF-17 and its 24 kDa fragment (see above) were 
performed as described in [9]. Peptides from the 
24 kDa fragment were obtained by digestion of 
about 10-25 nmol polypeptide with TPCK trypsin 
or Staphylococcus aureus V8 protease according to 
standard procedures [10]. On the other hand, in- 
tact S-pyridylethylated EF-17 proved to be rather 
refractory to tryptic digestion. Satisfactory results 
were obtained by using 2-4 nmol of heat 
denatured, finely suspended protein in 0.2 M 
(NH4)2CO3, pH 8.5, which was digested with 10/zg 
TPCK trypsin. After 3 h at 37°C, another 10/zg 
enzyme was added, and incubation was continued 
for 3 h at 37°C (see fig.lc). Alternatively, 
2 -4  nmol protein were dissolved in 0.2 M 
(NH4)2CO3, pH 8.0, and 6.5 M urea, and 10/zg 
TPCK trypsin was added. After 3 h at 37°C, an 
equal amount of enzyme was added, and incuba- 
tion was continued for 15 h at 37°C (see fig.ld). 
Peptides were separated by reverse-phase high- 
performance liquid chromatography on a Waters 
/zBondapak C18 column (4 x 300 mm) which was 
developed with a linear gradient of 0 to 75% (v/v) 
acetonitrile in 0.1% (v/v) trifluoroacetic acid over 
a period of 60 or 120 min, and with a flow rate of 
1.0 ml/min. In cases where the peaks of the 
chromatogram represented peptide mixtures, 
subsequent separations were performed on the 
same column, but with another electrolyte, e.g. 
10 mM triethylammoniumphosphate (pH 5.8) in- 
stead of 0.1% (v/v) trifluoroacetic acid (not 
shown). 
2.4. Protein sequence analysis 
Typically, 4-5 nmol peptide were used for se- 
quencing on a Beckman model 890 C sequencer. 
With the Applied Biosystems gas-phase sequencer 
model 470A, on-line equipped with a model 120A 
PTH-amino acid analyser, amounts of 
100-200 pmol peptide were used. 
2.5. Screening of an Artemia cDNA library 
An Artemia cDNA library was constructed in 
Agtll and screened with a polyclonal rabbit an- 
tiserum as described before [8]. Rabbit anti- 
EF-lZ?7 raised against EF-lz?7 was used as an- 
tiserum. Possible EF-I-y clones were subjected to 
an epitope selection according to [11]. In short the 
method is as follows. The purified immunopositive 
recombinants were plated out. As a control an im- 
munopositive insulin reecptor clone was used 
which is not recognized by anti-EF-1/? 7. A filter 
soaked in 10 mM IPTG(fl-D-thiogalactopyrano- 
side) was placed on the top agar and the plates 
were incubated overnight at 37°C. The filters were 
removed and incubated with rabbit anti-EF-1/37. 
After washing, the remaining antibody which had 
recognized the fusion protein, was eluted from the 
filter with a glycine-HCl, pH 2.3, buffer, The an- 
tibody thus purified, was allowed to react with 
EF-17 on a protein blot of an Artemia S100 extract 
as described in [12] and thus proved to be indeed 
anti-EF-17. The immunopositive EF-I-r recombi- 
nant was subcloned in PUC8. This EF-I-r cDNA 
clone was used to screen an Artemia PUC9 cDNA 
library. 
2.6. DNA sequencing analysis 
The immunological cDNA clone was subcloned 
in PUC8. The cDNA clones were sequenced using 
the sequencing technique of Maxam and Gilbert 
[131. 
2.7. RNA blot analysis 
Poly(A)-rich RNA was isolated, separated and 
blotted as described [7]. Northern blot hybridiza- 
tion was carried out as in [14]. The blot was 
reprobed with an EF-lce clone (2E3) [15]. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the chromatographic separation of 
the peptides used for direct sequence analysis. The 
amino acid sequences are indicated in the legends. 
Together with the N-terminal sequences obtained 
for intact EF-17 (28 residues) and its 24 kDa frag- 
ment (16 residues), they comprise more than half 
of the total sequence (see fig.3). 
After screening the Agtll cDNA library with 
rabbit anti-/YT, four positive clones out of 100000 
recombinants were selected. Three of the four 
clones were also positive with an EF- 1/5' cDNA pro- 
be. The remaining immunologically positive clone 
was submitted to an epitope selection. In this way 
the immunological clone was identified as an 
EF-17 cDNA clone and subsequently subcloned in 
PUC8. This subclone was designated ASEFlc2 
and from its sequence, it was clear that it did not 
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Fig. 1. (a) Tryptic peptides from the S-carboxymethylated 24 kDa fragment of EF-17. I, AKPEKK*; II, AKPEK*; III, 
KFNQGK*; IV, IFK*; V, KLDPDAQETK*; VI, FYSNNEETK*; VII, YQDELAK*; VIII, SKDPFDE- + GQDLA-; 
IX, SKDPFDEMPK* + GQDLAFK*; X, GTFNMDDFK*; XI, SKDPFDEMPK*; XII, GTFNMDDFK* + 
EQEEPADAAEEALAAEPK*; XIII, FDKENYSIWYSEYK*; XIV, SIPYFWEK*; XV, LSPDWQIDYESYDWK*; 
XVI, DLVTQYFTWTGTDK*. (b) Peptides from the S-carboxymethylated 24 kDa fragment of EF-IT, generated with 
Staphylococcus aureus V8 protease. I, KKEVPKKE*; II, QEEPADAAEE*; III, KKEVPKKEQEEPADAAEE*; IV, 
SYDWKKLDPDAQE*; V, ALAAEPKSDPF-; VI, TKSIPYFWE*; VII, TKDLVTQYFTWTGTDKQGRKFNQGKif-; 
VIII, ALAAEPKSKDPFDE*. (c) Tryptic peptides from S-pyridylethyl EF-I7 (heat-denatured, see section 2). The 
gradient was developed in 60min instead of 120min. I, SDAFLK* + GQDLAFK*; II, AVIGDF-; III, 
SFVFGETNK* + LYTYPENFR*; IV, ALEALDDHLLTR*; V, FDKENYSIWYSEYK*; VI, SIPYFWEK*; VII, 
LSPDWQIDYESYDWKK*; VIII, WFMTLINQK* + VYM--NLITGM-; IX, DLVTQYFSWTGTDK* + 
VPAFESADG--IAESNAI-. (d) Tryptic peptides from S-pyridylethyl EF-17 (digestion in urea solution, see section 2). 
I, FYSNNEETK*; II, ALIAAQY-GA-; III, LYTYPENFr*; IV, SKDPFDEMPK* + SIPYF*; V, L-PDWQIDYE-; VI, 
DLVTQ--S-TG-; VII, DLVTQYFS-TGTD-; VIII, VPA-ESADG-. The long digestion time caused the formation of 
many autolysis products of trypsin. * The peptide was sequenced to the end. Underlining indicates adifference between 
direct protein sequencing and cDNA derived protein sequencing. 
harbour a full length copy of cDNA for EF-17. 
Therefore an Artemia PUC9 cDNA library was 
screened by hybridization with the ASEFlc2 
cDNA probe and in this way ASEFlc3 was picked 
up. The complete cDNA sequencing strategy is 
shown in fig.2. On Northern blot a single band was 
found at the position roughly expected for the size 
of an mRNA corresponding to EF-17. The com- 
plete nucleotide sequence of EF-17 cDNA and the 
cDNA derived amino acid sequence are shown in 
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Fig.2. Sequencing strategy of the overlapping cDNA clones ASEFIc2 and ASEFlc3. Both strands of the cDNA were 
sequenced. Only relevant sites are indicated: A, AvaI; B, BamHI; D, DdeI; E, EcoRI; F, FokI; H, HindIII; R, RsaI; 
S, Sau3AI. 
fig.3 together with partial sequences obtained by 
direct protein sequence analysis. 
The translational initiation codon ATG starts at 
position 13 and the open reading frame terminates 
with stop codon TAA at position 1302. The initia- 
tion sequence AAGAUGG resembles more the in- 
itiation sequence AA(A/C)AUGG found in 
Drosophila [16] than the initiation sequence AC- 
1 
(M) V A G K L Y T Y P E N F R A F K A L I A A O Y S G A K L E I A K S F V  
ACTAA~A~GATGG~CT~ATA~ACATAT~CA~G~C~GG~TCT~A~G~GCCC~TA~CAG~Cc~C~G~cC~AG~GTC~2~ 
36 F G E T N K S D A F L K S F P L G K V P A F E S A D G H C I A E S N A I A Y Y V  
~GG~C~T~TGATGCC~rr r rK~A~CCT~T~CA~TTTTG~Tc~C~A~GA~cA~G~GT~TGCTATAGC~A~A~ 240 
76 
116 
156 
A N E T L R G S S D L E K A O l  I QW H T F A D T E I L P A S C T W V F P V L C 
GCT~TGAAACAC~G~G~CAGcAGCGAC~GGA~GGCTC~AA~A~C~GATGACTTTTGC~ATA~AAA~CTCCcTGCATCGTGTACC~GG~CCC~TC~AGGT 
I M O F N K O A T A R A K E D I D K A L O A L D D H L L T R T Y L V G E R I T L  
A~A~C~TI~r~C~C~GG~TA~GGCCCGAGCAAAGGAGGATA~GACAAAGCCC1~rC~GCC~AGA~ACCATC~C~AC~G~C~A~CTAGTAGGGG~LAGGA~ACC~A 
J 
A D I V V T C T L L H L Y O H V L D E A F R K S Y V N T N R W F I T L I N Q K Q  
GCT~ATA~G~GT~CATGCACA~GCTCCATCTCTATC~GCATGTTTTGGACGAGGcTTTTAGA~TC~ATGTC~TACC~CCGCTGGTTTATCA~TCT~CC~G~Gc~G 
360 
480 
600 
,196 V K A V 1 G D F K L C E K A G E F D P K K Y A E F 0 A A I G S G E K K K T E K A 
GTCAAGG CTOTM~'~TGG CGACTTCAAG CTGTG CGMUL~OOCTGGTGAA'~rCGATCCAAAGJL~GTATGCTGAGI~J'C CAGG CAG CTATCGGAAGTGGAG~O~G~GACAG~OO CC 720 
236 
276 
316 
356 
P K A V K A K P E K K E V P K K E QE  E P A D A A E E A L A A E P K S K D P P D 
CCGAAAGCAGTGAAAGCA~CCAGA~GAAGGAAGTGCCAAAGAAAGAGC~AGAAGAACCAGCAGATG TG CTG GA GCTCTTGCAG T AACCCAAGAGCAAGGATCCCTTTGAT 
E M P K G T F N M D D F K R P Y S N N E E T K S 1 P ¥ F • E K P D K E N Y S I ~/ 
GAGATGCCCAAGGGAACGTTCAACAIT, GATGACTTCAAGCGTTTCTACTCCAACAACGAGGAAAC C TCAATCC ATACTT~GGAGAAGTTTGACAAGGAAAA~ACTC~TC~G 
Y S E Y K ¥ 0 D E L A K Y Y M S C N L 1 T G M F 0 R I E K H R K QA F A S V C V 
TATAGTGAATATAAGTATC~AGATGAACT~C AAAGTTTACATGTCATG CAACCTTATTACGGGTATGTTCCI[GCGAATAGAA~AGATGAGAAAGC~AG CATTTGCCT~G~CGTA 
F G E D N D S S I S G I W V W R G 0 D L A F K L S P D W 0 I D ¥ E S Y D W K K L 
TTT~TGAAGACAACGATTC~TcCATTTCTGGCATATG~GTCTGGAGAGGTcf~A~ACCTAGCCTTCAAGTTGAGTCCCGATTGGc~GATCGACTACGAATCGTATGACTGGAAGAAACTT 
840 
960 
1080 
1200 
396 D P D A 0 E T K D L V T O Y F T W T G T D K O G R K ¥ N Q G K I ¥ K 
GA~C~ATGCGc~A~AAACAAAGGATTTAGTGACAC~GTA~TT~ACTTGGAcTGGT~CGG~CAAAC~AG~TCGCAAGTTCAATC~A~C C ~TCTT'rAAGTAAATCAGAAGA~C~G 1320 
lu~rKGGAGGTGTTACGAAGTTTTCTATCAAATTCTTTGCTGAATAAAAGAGAGTCAATCGTTAAAAAAAAAAAAAA 1397 
Fig.3. The cDNA sequence and the nucleotide derived amino acid sequence of EF-17. The amino acid sequence is shown 
in the one letter code. Segments found by direct protein sequencing are marked by - - ,  and covers about half of the 
total sequence (see also fig. 1). An asterisk marks the positions where direct protein sequencing differs from the primary 
structure derived from cDNA: Q-136 (cDNA) corresponds to E-136 (protein); 1-188 (cDNA) corresponds to M-188 
(protein); T-411 (cDNA) corresponds to S-411 or T-411 (protein, depending on the batch used). See also section 3. (I) 
Start of the 24 kDa fragment, which comprises the complete C-terminal moiety of the original protein. The 
polyadenylation signal is underlined. 
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CAUGG found by Kozak [17] in vertebrates. The 
polyadenylate signal AATAAA [18] was located at 
position 1363 to 1368. Both clones ASEFlc2 and 
ASEFlc3 have a poly(A) stretch as shown in fig.3. 
The predicted EF-17 protein sequence consists 
of 429 amino acids, excluding the initiator 
methionine. The polypeptide chain has a 
calculated molecular mass of 49200 Da. The 
isolated protein lacks the initiator methionine at its 
amino terminus, and is not amino-terminally 
blocked as is the case with EF-I~ and EF-lfl. This 
mode of processing is in line with the rule that 
when the residue next to the initiator methionine is
a valine, the methionine will be removed and the 
amino-terminus will not be acetylated [19]. The 
protein is relatively rich in aromatic residues (13°70) 
and contains a highly polar central region, which 
is amenable to endogenous proteolytic attack. This 
leaves a fragment which comprises the C-terminal 
part of the protein, starting from residue 241. 
There are no hydrophobic domains of sufficient 
length in EF-17 to span the plasma membrane 
repeatedly. The length of the largest hydrophobic, 
uncharged stretch is 19 residues long (amino acid 
position 102-120). Judged from the hydrophobici- 
ty plot as shown in fig.4 we observed a remarkable 
alternation of hydrophobic and hydrophilic 
regions bordering a large hydrophilic region in the 
middle of the sequence. The EF-17 sequence does 
not contain a consensus sequence for ATP or GTP 
binding [21,22]. 
A short internal repeat VFGE-N-S is present at 
two sites in the protein at the positions 35-42 and 
355-362; at the nucleotide level this sequence 
homology is even more evident. 
Comparison of the derived and the directly 
determined amino acid sequence, revealed three 
differences. One of them at position 411 also 
showed microheterogeneity a  the protein level (see 
fig.3). In the other two cases the differences may 
be due to errors made by the reverse transcriptase 
enzyme [23] or cloning of a minor EF-17 mRNA. 
When two protein data banks NBRF and 
Swissplot were screened, no significant homology 
of EF-I-r with any known protein was found. 
In conclusion the amino acid sequence of EF-17 
reported here, should fit the findings that the 
overall negatively charged EF-lfl protein forms a 
Sequence position 
30 
T 2~' 
o 
...j 
a. 
Or - to  
--20 - 
l t I 
l 
I 
~ l ' ' ' ' l ' ' ' ' l  . . . .  t ~ " ~ ' l ' ' ' ' l ' ' ~ ' l l ' ~ ' l  ~ '~ 
so 1o~ , so  ~®o ~so  3oo  3~o ~® 
i 
,,I tl' L,t ,ll 
Fig.4. Hydrophobicity pattern of EF-I 7 according to Hopp and Woods [20]. Each point represents an average value 
over six amino acid residues. Negative values represent hydrophobic regions and positive values represent hydrophilic 
regions. 
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firm complex with EF-17, which seems instrumen- 
tal in anchoring the nucleotide xchange nzyme to 
certain structures in the cell [7]. In addition it is in- 
teresting that an extremely purified EF-lfl7 
preparation displays a protein kinase activity 
which phosphorylates EF- I~ but not EF- ly  (un- 
published; and [24]). 
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